Newsmakers

Worksport (NASDAQ: WKSP) to Open AI-Integrated Strategic Distribution Center to Boost National Sales Ramp Up

Expected improvements include 1-2-day delivery for major markets and early cost efficiencies of 10%-15% as volume increases. WEST SENECA, NEW YORK / December 8, 2025 / Worksport Ltd. (NASDAQ:WKSP) (“Worksport” or the “Company”), a U.S.-based […]

Newsmakers

Worksport (NASDAQ: WKSP) Achieves Historic Online Sales Milestone With Record Black Friday Performance

400% YoY Increase; Direct-to-consumer e-commerce single day sales exceed $200,000 and weekly sales reach $665,000 WEST SENECA, NY / December 2, 2025 / Worksport Ltd. (NASDAQ:WKSP) (“Worksport” or the “Company”), a U.S.-based innovator in advanced manufacturing, clean […]

Newsmakers

Worksport (NASDAQ: WKSP) Announces HD3 Heavy-Duty Tonneau Cover Now Selling to B2B Dealers Following October Production Launch

Company Expands Dealer Offering with New Heavy-Duty Platform as COR and SOLIS Prepare for Initial Orders Opening November 28 West Seneca, New York, Nov. 25, 2025  — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), […]

Newsmakers

Worksport (NASDAQ: WKSP) Delivers 61% Revenue Growth and 31% Margin in Q3 2025; Positioned for 2026 Profitability with $45M+ Revenue Target

2026 outlook driven by $27M-$35M in tonneau cover sales, with additional major contributions anticipated from upcoming launches of the SOLIS solar-integrated tonneau cover and COR battery system.  West Seneca, New York, Nov. 13, 2025 — […]

Newsmakers

Worksport (NASDAQ: WKSP) Accelerates U.S. Expansion With Major Missouri Operations Upgrade to Integrate Custom SOLIS Solar Covers, Signaling Next Phase of Growth

Newly Leased Facility Strengthens Operational Capacity, Enhances Engineering Oversight, and Accelerates Commercial Readiness West Seneca, New York, Nov. 18, 2025– Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator in advanced manufacturing, clean […]

Newsmakers

Worksport (NASDAQ: WKSP) to Showcase SOLIS™ and COR™ at SEMA 2025, Expanding Global Distribution Opportunities

Company to Meet Dealers, Distributors and Showcase Industry-Defining Clean-Tech Solutions — SOLIS Solar Tonneau and COR Portable Energy System — in SEMA’s “New Product” Evaluation Category West Seneca, New York, Nov. 03, 2025  — Worksport […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) Launches VA-Backed Study of Novel GDNF Weight Loss Therapy Targeting Obesity and Fatty Liver Disease

Collaborative program with the U.S. Department of Veterans Affairs aims to validate GDNF as a first-in-class biologic for obesity and hepatic health. NEW YORK, Oct. 27, 2025  — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) Reports FDA Orphan Drug Designation and Strong Preclinical Data for HT-KIT in Rare c-KIT-Driven Cancers

>80% KIT knock-down and significant tumor-volume reduction in systemic mastocytosis and GIST models; GLP-validated bio analytics complete; Japan Patent protects through 2039 as IND work advances. Planned Next Steps (Near-Term): Complete GLP toxicology and CMC packages; submit […]

Newsmakers

Worksport Ltd. (NASDAQ: WKSP) Successfully Closes $10 Million Regulation A Funding; Launch-Ready and Fully Capitalized for Early 2026 Cash Flow Positivity

Offering complete with capital overhang removed; $4.50 warrants provide future success-based capital as Worksport targets Q4 flagship launches and growth execution. West Seneca, New York, Oct. 15, 2025 — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform

Under the new entitlement agreement, Hoth Therapeutics secures annual NVIDIA AI Enterprise Essentials licenses to support its GPU-powered infrastructure, enabling advanced machine learning and neural network modeling capabilities for pharmaceutical research NEW YORK, Oct. 8, 2025  […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025

Presentation to highlight advancements in Hoth’s clinical pipeline, including HT-001 for cancer-therapy-induced rash and HT-KIT, a novel oncology program targeting KIT-driven tumors NEW YORK, Oct. 7, 2025  — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company […]